Latest Lupus anticoagulant Stories
A study led by Hospital for Special Surgery researchers has demonstrated that women who have a specific type of antibody that interferes with blood vessel function are at risk for adverse pregnancy outcomes and that other antibodies in the same family thought to cause pregnancy complications do not put women at risk. The researchers say that many doctors may be unnecessarily treating some pregnant women who have antiphospholipid antibodies (aPLs) with anticoagulants, such as expensive...
Funding Aims to Improve Lupus Diagnosis and Treatment NEW YORK, Dec. 16, 2011 /PRNewswire-USNewswire/ -- A top legislative priority of the Lupus Research Institute (LRI) -- funding for a nationwide lupus education effort for health providers -- is included in the Fiscal 2012 omnibus appropriations bill (HR 2055) passed today in the House of Representatives and now moving to the Senate for a vote before going to the President for signature. The legislation allocates nearly $1...
Lupus is a disease where the immune system attacks healthy cells of the body. This leads to progressive damage of different tissues and organs. The classical characteristic of the disease is the so-called butterfly rash in the face. Many Lupus patients eventually die of kidney failure. Scientists at the Max Planck Institute for Infection Biology in Berlin together with medical scientists from the University of Erlangen succeeded in elucidating basic principles of the disease. This opens up...
Hadasit Bio-Holdings, a subsidiary of Hadasit, has announced that one of its portfolio companies, Verto, has successfully completed a human clinical trial of a device for treating patients who suffer from systemic lupus erythematosus. The goals of the trial at the Hadassah Medical Center in Ein Kerem, in which ten lupus patients took part, were to demonstrate the safety and efficacy of the Lupusorb, developed by Verto. The treatment was successful and achieved the goals. Verto is said to...
